Omeros (OMER) Net Margin (2010 - 2026)
Omeros (OMER) posted Net Margin of 48.63% for Q1 2026, down 54.71% sequentially from 107.36% in Q2 2022.
Omeros (OMER) Net Margin (2010 - 2026) Analysis & Trends
Omeros has reported Net Margin for 14 years, with the latest figure at 48.63% in Q1 2026.
- Quarterly Net Margin changed N/A year-over-year to 48.63% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 8.02% (up 4505.0% YoY) and the FY2020 annual result came in at 47.51%, down 873.0% from the prior year.
- Net Margin retreated to 48.63% in Q1 2026 per OMER's latest filing, from 107.36% in the prior quarter.
- Over five years, Net Margin peaked at 107.36% in Q2 2022 and troughed at 48.63% in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 32.99% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 30.23% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 30.33% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 13.90% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 30.98% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 12.09% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 12.74% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -3.12% |
| 10 | Omeros | 1.24 Bn | 1.24 Bn | 27.73 Mn | 23.12% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 23.12% |
| Mar 31, 2026 | 48.63% |
| Jun 30, 2022 | 107.36% |
| Mar 31, 2022 | 92.67% |
| Dec 31, 2021 | -411.75% |
| Sep 30, 2021 | 71.91% |
| Jun 30, 2021 | 74.92% |
| Mar 31, 2021 | 69.70% |
| Dec 31, 2020 | -899.18% |
| Sep 30, 2020 | -147.29% |
| Jun 30, 2020 | -507.88% |
| Mar 31, 2020 | -125.67% |
| Dec 31, 2019 | -334.80% |
| Sep 30, 2019 | -55.14% |
| Jun 30, 2019 | -228.96% |
| Mar 31, 2019 | -114.05% |
| Dec 31, 2018 | -65.57% |
| Sep 30, 2018 | -3,687.63% |
| Jun 30, 2018 | -6,579.46% |
| Mar 31, 2018 | -1,921.54% |